Birmingham Digestive Health Research

Homewood, Alabama 35209

1 studies enrolling now · 2 studies all time

What they study most

Celiac Disease, Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis

Studies at this site

• Study of DONQ52 in Active Celiac Disease — Recruiting now
• Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus — Completed